Citation: Jd. Eudy et al., Identification and characterization of the human and mouse SLC19A3 gene: Anovel member of the reduced folate family of micronutrient transporter genes, MOL GEN MET, 71(4), 2000, pp. 581-590
Authors:
Spiegelstein, O
Kroetz, DL
Levy, RH
Yagen, B
Hurst, SI
Levi, M
Haj-Yehia, A
Bialer, M
Citation: O. Spiegelstein et al., Structure activity relationship of human microsomal epoxide hydrolase inhibition by amide and acid analogues of valproic acid, PHARM RES, 17(2), 2000, pp. 216-221
Authors:
Spiegelstein, O
Yagen, B
Bennett, GD
Finnell, RH
Blotnik, S
Bialer, M
Citation: O. Spiegelstein et al., Stereoselective pharmacokinetic analysis of valnoctamide, a CNS-active chiral amide analogue of valproic acid, in dogs, rats, and mice, THER DRUG M, 22(5), 2000, pp. 574-581
Authors:
Roeder, M
Spiegelstein, O
Schurig, V
Bialer, M
Yagen, B
Citation: M. Roeder et al., Absolute configuration of the four stereoisomers of valnoctamide (2-ethyl-3-methylvaleramide), a potentially new stereospecific antiepileptic and CNSdrug, TETRAHEDR-A, 10(5), 1999, pp. 841-853
Authors:
Spiegelstein, O
Bialer, M
Radatz, M
Nau, H
Yagen, B
Citation: O. Spiegelstein et al., Enantioselective synthesis and teratogenicity of propylisopropyl acetamide, a CNS-active chiral amide analogue of valproic acid, CHIRALITY, 11(8), 1999, pp. 645-650
Authors:
Spiegelstein, O
Yagen, B
Levy, RH
Finnell, RH
Bennett, GD
Roeder, M
Schurig, V
Bialer, M
Citation: O. Spiegelstein et al., Stereoselective pharmacokinetics and pharmacodynamics of propylisopropyl acetamide, a CNS-active chiral amide analog of valproic acid, PHARM RES, 16(10), 1999, pp. 1582-1588
Citation: O. Spiegelstein et al., Structure-pharmacokinetic-pharmacodynamic relationships of N-alkyl derivatives of the new antiepileptic drug valproyl glycinamide, EPILEPSIA, 40(5), 1999, pp. 545-552